- Home
- LICN vs ZTEK Comparison
LICN vs ZTEK Comparison
Compare LICN & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LICN
- ZTEK
- Stock Information
- Founded
- LICN 2004
- ZTEK 2008
- Country
- LICN China
- ZTEK Canada
- Employees
- LICN 406
- ZTEK 25
- Industry
- LICN
- ZTEK Major Chemicals
- Sector
- LICN
- ZTEK Industrials
- Exchange
- LICN Nasdaq
- ZTEK Nasdaq
- Market Cap
- LICN 2.0M
- ZTEK 103.3M
- IPO Year
- LICN 2023
- ZTEK N/A
- Fundamental
- Price
- LICN $3.53
- ZTEK $1.11
- Analyst Decision
- LICN
- ZTEK
- Analyst Count
- LICN 0
- ZTEK 0
- Target Price
- LICN N/A
- ZTEK N/A
- AVG Volume (30 Days)
- LICN 93.2K
- ZTEK 24.5K
- Earning Date
- LICN 01-01-0001
- ZTEK 02-28-2025
- Dividend Yield
- LICN N/A
- ZTEK N/A
- EPS Growth
- LICN 36.90
- ZTEK N/A
- EPS
- LICN 55.10
- ZTEK N/A
- Revenue
- LICN $41,929,000.00
- ZTEK $44,936.00
- Revenue This Year
- LICN N/A
- ZTEK N/A
- Revenue Next Year
- LICN N/A
- ZTEK N/A
- P/E Ratio
- LICN $0.06
- ZTEK N/A
- Revenue Growth
- LICN 24.86
- ZTEK 92.38
- 52 Week Low
- LICN $0.04
- ZTEK $0.50
- 52 Week High
- LICN $7.55
- ZTEK $1.31
- Technical
- Relative Strength Index (RSI)
- LICN 50.96
- ZTEK 53.84
- Support Level
- LICN $2.60
- ZTEK $1.06
- Resistance Level
- LICN $3.78
- ZTEK $1.23
- Average True Range (ATR)
- LICN 0.60
- ZTEK 0.09
- MACD
- LICN -0.12
- ZTEK 0.00
- Stochastic Oscillator
- LICN 36.33
- ZTEK 63.64
About LICN Lichen China Limited
Lichen International Ltd formerly Lichen China Ltd is a holding company. The company, along with its subsidiaries provides financial and taxation solution services; education support services; and software and maintenance services. The company generates Majority revenue from Financial and taxation solution services.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.